HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

AuthorsNadera J Sweiss, Michael Jude Welsch, James J Curran, Michael H Ellman
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 53 Issue 5 Pg. 788-91 (Oct 15 2005) ISSN: 0004-3591 [Print] United States
PMID16208666 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal (therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sarcoidosis (complications, drug therapy, pathology)
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: